Works by Brioschi, Filippo
Results: 6
Single‐center study on SARS‐CoV‐2 infection in patients affected by CML: Vaccination status and bosutinib therapy as possible protective factors for hospitalization.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 8, p. 9662, doi. 10.1002/cam4.5923
- By:
- Publication type:
- Article
Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 123, doi. 10.1002/hon.2808
- By:
- Publication type:
- Article
Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approach.
- Published in:
- 2019
- By:
- Publication type:
- journal article
An Imatinib–non‐responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization.
- Published in:
- Clinical Case Reports, 2020, v. 8, n. 1, p. 71, doi. 10.1002/ccr3.2531
- By:
- Publication type:
- Article
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK)‐positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. E319, doi. 10.1002/ajh.25967
- By:
- Publication type:
- Article
Feasibility and effectiveness of the prolonged use of eltrombopag in addition to immunosuppression in patients with acquired aplastic anemia: a single-center real-life experience.
- Published in:
- Platelets, 2024, v. 35, n. 1, p. 1, doi. 10.1080/09537104.2024.2415483
- By:
- Publication type:
- Article